EXPERIMENTAL DRUG TRIAL FOR BUNDIBUGYO EBOLA VIRUS
Why in the News? ● Clinical Trial: The Democratic Republic of Congo (DRC) has launched a clinical trial to evaluate Gilead Sciences’ experimental antiviral drug Obeldesivir as a post-exposure treatment for the ongoing Bundibugyo Ebola virus outbreak in Congo and Uganda. ● Research Initiative: The study seeks to determine whether early antiviral treatment after exposure…
